US5503558A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Osseointegration promoting implant composition, implant assembly and method therefor
Assignee: URIST REGENERATIVE MED Inc
•
Filing: 1993-11-12
•
Granted: 1996-04-02
•
Expires: 2013-11-12
Abstract
Abstract A liquid composition comprising a transforming growth factor β (TGF-β) in a liquid carrier which gels at about 37° C., promotes osseointegration of an implant in bone, when introduced into a bore in the bone, prior to insertion of the implant in the bone; a method of placing an implant in bone comprises injecting said liquid composition into a bore in the bone prior to insertion of the implant in the bore, the TGF-β being present in the liquid composition in a concentration effective in an interspace between an inner surface of the bore and an outer surface of the implant, to promote osseointegration.
Inventors
- 👤 Cameron M. L. Clokie
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:48
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/18; A61K38/1841; A61C; A61C8/00; A61C8/0018; A61C8/0048; A61C8/005; A61C8/0054; A61C8/0069; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/227; A61P; A61P19/00; A61C8/006
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
111 words
In a method of placing an implant in bone, in which a bore is formed in the bone and the implant is inserted into the bone, the improvement in which a liquid composition comprising a transforming growth factor β (TGF-β) in a liquid carrier is injected into said bore prior to insertion of the implant in the bore, said liquid carrier being gelable at about 37° C., and said TGF-β being present in said liquid composition in a concentration effective in an interspace between an inner surface of said bore and an outer surface of said implant, to promote osseointegration at the interface between said inner surface and said outer surface.
Claim 2
Dependent Claim
111 words
In a method of placing an implant in bone, in which a bore is formed in the bone and the implant is inserted into the bone, the improvement in which a liquid composition comprising a transforming growth factor β (TGF-β) in a liquid carrier is injected into said bore prior to insertion of the implant in the bore, said liquid carrier being gelable at about 37° C., and said TGF-β being present in said liquid composition in a concentration effective in an interspace between an inner surface of said bore and an outer surface of said implant, to promote osseointegration at the interface between said inner surface and said outer surface.
Claim 3
Dependent Claim
14 words
A method according to claim 1, in which said TGF-β is TGF-β 1 .
Claim 4
Dependent Claim
30 words
A method according to claim 2, in which at least an outer portion of said implant is of titanium and an outer surface of said outer portion is oxidized titanium.
Claim 5
Dependent Claim
13 words
A method according to claim 3, in which said implant is of titanium.
Claim 6
Dependent Claim
16 words
A method according to claim 3, in which said implant has a core of a non-metal.
Claim 7
Dependent Claim
14 words
A method according to claim 3, in which said liquid carrier is a collagen.
Claim 8
Dependent Claim
29 words
A method according to claim 3, in which said liquid carrier is a polyoxyalkylene block copolymer having a molecular weight of at least 1000 and bearing terminal hydroxyl groups.
Claim 9
Dependent Claim
31 words
A method according to claim 7, wherein said interspace has a width of 10 μm to 100 μm and said composition contains 0.5 to 20 μg/ml of said TGF-β 1 .
Claim 10
Dependent Claim
137 words
An implant assembly comprising, in combination: i) an osseointegration promoting implant composition comprising a transforming growth factor β (TGF-β) in a liquid carrier, said liquid carrier being gelable at about 37° C., said TGF-β being present in said liquid carrier in an amount effective to promote osseointegration at the interface between a bore in a bone for an implant, and an outer surface of the implant, and ii) an implant component having a stem for insertion in a bore in a bone, and a support base for a prosthesis integral with said stem, said support base being located at a terminal end of said stem and having means to anchor the prosthesis, said composition having a liquid form adapted to be injected in a bore in a bone prior to insertion of said stem in the bore.
Claim 11
Dependent Claim
137 words
An implant assembly comprising, in combination: i) an osseointegration promoting implant composition comprising a transforming growth factor β (TGF-β) in a liquid carrier, said liquid carrier being gelable at about 37° C., said TGF-β being present in said liquid carrier in an amount effective to promote osseointegration at the interface between a bore in a bone for an implant, and an outer surface of the implant, and ii) an implant component having a stem for insertion in a bore in a bone, and a support base for a prosthesis integral with said stem, said support base being located at a terminal end of said stem and having means to anchor the prosthesis, said composition having a liquid form adapted to be injected in a bore in a bone prior to insertion of said stem in the bore.
Claim 12
Dependent Claim
13 words
A combination according to claim 9, wherein said TGF-β is TGF-β 1 .
Claim 13
Dependent Claim
30 words
A combination according to claim 10, wherein at least an outer portion of said implant component is of titanium and an outer surface of said outer portion is oxidized titanium.
Claim 14
Dependent Claim
13 words
A combination according to claim 11, wherein said liquid carrier is a collagen.
Claim 15
Dependent Claim
42 words
A combination according to claim 11, wherein said liquid carrier is a block copolymer of formula: HO(CH.sub.2 CH.sub.2 O).sub.a -(CH(CH.sub.3)CH.sub.2 OH).sub.b (CH.sub.2 CH.sub.2 O).sub.c H where b comprises at least 15%, by weight, and segments a+c comprise 20 to 85%, by weight.
Claim 16
Dependent Claim
28 words
A combination according to claim 9, wherein said liquid carrier is a polyoxyalkylene block copolymer having a molecular weight of at least 1000 and bearing terminal hydroxyl groups.
Claim 17
Dependent Claim
20 words
A combination according to claim 14, wherein said TGF-β 1 is present in a concentration of 5 to 15 μg/ml.
References Cited (Backward Citations)
EP0321277A2
Cited
US4904187A
Cited
EP0361896A2
Cited
WO1990004974A1
Cited
US4976736A
Cited
US5158934A
Cited
US5236456A
Cited
US5208219A
Cited
US5118667A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-04-02 | 1999-10-02 | 2000-04-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-04-02 | 2003-10-02 | 2004-04-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-04-02 | 2007-10-02 | 2008-04-02 | $7700.00 | Window Closed / Lapsed |